Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
IL-13 and calpain-14 suppress the expression of SPINK7 by regulating OVOL1 in eosinophilic esophagitis
Nurit P. Azouz, Andrea M. Klingler, Sierra S. Beach, Kalen Rossey, Mark Rochman, Misu Paul, Julie M. Caldwell, Michael Brusilovsky, Alexander T. Dwyer, Xiaoting Chen, Daniel Miller, Carmy Forney, Leah C. Kottyan, Matthew T. Weirauch, Marc E. Rothenberg
Nurit P. Azouz, Andrea M. Klingler, Sierra S. Beach, Kalen Rossey, Mark Rochman, Misu Paul, Julie M. Caldwell, Michael Brusilovsky, Alexander T. Dwyer, Xiaoting Chen, Daniel Miller, Carmy Forney, Leah C. Kottyan, Matthew T. Weirauch, Marc E. Rothenberg
View: Text | PDF
Research Article Gastroenterology Immunology Inflammation

IL-13 and calpain-14 suppress the expression of SPINK7 by regulating OVOL1 in eosinophilic esophagitis

  • Text
  • PDF
Abstract

Eosinophilic esophagitis (EoE) is a type 2 allergic disease characterized by esophageal inflammation and epithelial cell dysfunction. The acquired loss of the anti–serine protease of kazal type 7 (anti-SPINK7) in the squamous epithelium of the esophagus has a causal role in EoE pathogenesis. However, there is a limited understanding of the factors that regulate its expression and responsiveness to inflammatory stimuli. Herein, we have identified the transcription factor, ovo like transcriptional repressor 1 (OVOL1), as an esophageal selective gene product that regulates SPINK7 promoter activity. Overexpression of OVOL1 increased SPINK7 expression, whereas its depletion decreased SPINK7 expression, impaired epithelial barrier, and increased production of the proatopy cytokine thymic stromal lymphopoietin (TSLP). Stimulation with IL-13 abrogated the nuclear translocation of OVOL1 and promoted enhanced degradation of OVOL1 protein. This effect of IL-13 was dependent on the esophageal specific cysteine protease calpain-14 at least in part. Analysis of human esophageal biopsies demonstrated that the expression of esophageal OVOL1 correlated with SPINK7 transcript expression and was lost as a function of EoE disease activity. In summary, our study identifies key regulatory mechanisms in EoE pathogenesis, demonstrating that OVOL1 promotes SPINK7 transcription, whereas IL-13 suppresses this pathway in EoE.

Authors

Nurit P. Azouz, Andrea M. Klingler, Sierra S. Beach, Kalen Rossey, Mark Rochman, Misu Paul, Julie M. Caldwell, Michael Brusilovsky, Alexander T. Dwyer, Xiaoting Chen, Daniel Miller, Carmy Forney, Leah C. Kottyan, Matthew T. Weirauch, Marc E. Rothenberg

×

Figure 1

SPINK7 expression as a function of calcium and cell confluency.

Options: View larger image (or click on image) Download as PowerPoint

SPINK7 expression as a function of calcium and cell confluency.
(A) Qua...
(A) Quantitative polymerase chain reaction (qPCR) of SPINK7 expression in EPC2 in cells. (B) CHIP peaks H3K27Ac in the promoter region of SPINK7 in EPC2 cells in the indicated conditions. (C) Heatmap depicting the relative expression of the indicated genes in epithelial clusters on the basis of single-cell RNA-seq data of dispersed cells from esophageal control biopsies. (D) Promoter activity in cells grown in high calcium and high confluency, cotransfected with either nano-luciferase (nLUC) vector containing the SPINK7 promoter (SPINK7) or a promoterless nLUC vector and with firefly vector to control for transfection efficiency (Control), presented as relative luminescence units (RLU). (E) Promoter activity in cells cotransfected with SPINK7-nLUC that were grown in the indicated concentrations of CaCl2 and normalized to cells cotransfected with nLUC and firefly vector. (F) Promoter activity in cells that were grown in 1.8 mM of CaCl2 and cotransfected with nLUC constructs that contain either 0, 1, 2, 3, 4, or 4.5 kb of the SPINK7 promoter sequence and firefly vector. (G) Promoter activity in cells cotransfected with nLUC constructs, containing either 0, 1, 2, 3, 4, or 4.5 kb of the SPINK7 promoter sequence and firefly vector, and grown in either 0.09 or 1.8 mM of CaCl2. The values of the 1.8 mM of CaCl2 lysates were divided to the values of the cells cultured in 0.09 mM of CaCl2. P values were calculated by 1-way ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts